FDA Inspection 1195740 — Endo USA, Inc.
The FDA completed an inspection of Endo USA, Inc. on December 22, 2022 in Horsham, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 22, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Horsham, PA (United States)